Repeat Bone Density Tests as Screening Tests
Yes, repeat bone density tests are covered as screening tests, but they should follow specific intervals based on baseline results and risk factors. 1
Recommended Intervals for Repeat Bone Density Screening
The U.S. Preventive Services Task Force (USPSTF) provides guidance on repeat bone density testing as a screening tool:
- Minimum interval: A minimum of 2 years between tests is needed to reliably measure changes in bone mineral density due to limitations in testing precision 1
- Individualized intervals: Longer intervals may be appropriate for identifying new cases of osteoporosis, with frequency determined by:
- Age (older women need more frequent screening)
- Baseline bone mineral density (lower BMD requires more frequent screening)
- Presence of other risk factors for fracture 1
Higher Yield Groups for Repeat Screening
Repeat screening will provide greater clinical benefit in:
- Older women
- Those with lower bone mineral density at baseline
- Individuals with multiple risk factors for fracture 1
Special Considerations for Different Populations
For Women Under Age 65
- Women aged 60-64 with risk factors should receive screening comparable to routine screening in older women 1
- Key risk factors include:
- Low body weight (weight < 70 kg) - strongest single predictor
- No current use of estrogen therapy
- Prior fractures 1
For Monitoring Treatment Response
- Patients diagnosed with osteoporosis are no longer in the screening context
- These patients may require additional testing for:
- Diagnostic purposes
- Monitoring response to treatment 1
Technical Aspects of Bone Density Testing
- Preferred measurement: Femoral neck bone density measured by dual-energy x-ray absorptiometry (DXA) is the best predictor of hip fracture 1
- Measurement variability: Results can vary significantly depending on:
- Site and type of bone measurement test
- Number of sites tested
- Brand of densitometer used
- Reference range applied 1
Common Pitfalls to Avoid
- Testing too frequently: Testing more often than every 2 years typically cannot reliably detect true changes in bone density 1
- Using T-scores for premenopausal women: BMD Z-scores (not T-scores) should be reported for all children, adolescents, and premenopausal women 1
- Failing to adjust for growth factors in younger patients: For patients under 20 years, measurements should be adjusted for growth delay or maturational delay 1
- Not considering risk factors when determining screening intervals: Higher risk individuals benefit from more frequent screening 1
By following these evidence-based guidelines for repeat bone density testing, clinicians can appropriately screen patients while avoiding unnecessary testing, ultimately improving fracture risk assessment and prevention.